Document
false0001370053 0001370053 2020-01-15 2020-01-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: January 15, 2020
(Date of earliest event reported)

ANAPTYSBIO, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
001-37985
20-3828755
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
            
10421 Pacific Center Court, Suite 200
San Diego, CA 92121
(Address of Principal Executive Offices, and Zip Code)

(858) 362-6295
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a‑12 under the Exchange Act (17 CFR 240.14a‑12)
Pre‑commencement communications pursuant to Rule 14d‑2(b) under the Exchange Act (17 CFR 240.14d‑2(b))
Pre‑commencement communications pursuant to Rule 13e‑4(c) under the Exchange Act (17 CFR 240.13e‑4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01 Regulation FD.
AnaptysBio, Inc. plans to present the presentation attached hereto as Exhibit 99.1 at the J.P. Morgan Healthcare Conference on January 15, 2020.
The information furnished with this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
AnaptysBio, Inc.
 
Date: January 15, 2020
By:
/s/ Eric Loumeau
 
 
 
Name: Eric Loumeau
 
 
 
Title: Interim Chief Financial Officer and General Counsel
 



 
Exhibit


http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=8





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=9





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=10
http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=11





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=12





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=13





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=14





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=15





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=16





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=17





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=18





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=19





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=20





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=21





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=22





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=23





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=24





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=25





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=26





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=27





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=28





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=29





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=30





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=31





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=32





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=33





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=41





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=34





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=35





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=36





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=37





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=40





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=38





http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13303234&doc=39